Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant
Clinical trial NCT05959447 · COMPLETED
Trial details
- NCT number
- NCT05959447
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2023-10-13
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.